Ranbaxy to soon supply anti-ulcer drug Nexium’s low-cost version

13 May 2011 Evaluate

Ranbaxy Laboratories expects to start supplying a low-cost version of anti-ulcer drug, sold under the brand Nexium by AstraZeneca to the British drugmaker, towards the end of 2011. The drugmaker had entered into an agreement three years ago to supply a cheap version of the drug to Astra-Zeneca starting May 2010, that could fetch $40-50 million in annual revenues for Ranbaxy. The supply has been delayed due to pending approvals from the American drug regulator as the medicine is to be sold by AstraZeneca in the US.crackcrack

Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...